Penobscot Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $774K | Sell |
13,428
-350
| -3% | -$20.1K | 0.05% | 187 |
|
|
2026
Q1 | $836K | Sell |
13,778
-800
| -5% | -$46.6K | 0.07% | 182 |
|
|
2025
Q4 | $786K | Sell |
14,578
-500
| -3% | -$24.1K | 0.06% | 188 |
|
|
2025
Q3 | $680K | Sell |
15,078
-540
| -3% | -$25.2K | 0.05% | 197 |
|
|
2025
Q2 | $723K | Buy |
15,618
+126
| +0.8% | +$6.18K | 0.06% | 186 |
|
|
2025
Q1 | $945K | Buy |
15,492
+862
| +6% | +$50.2K | 0.09% | 163 |
|
|
2024
Q4 | $827K | Sell |
14,630
-498
| -3% | -$27.8K | 0.08% | 171 |
|
|
2024
Q3 | $783K | Sell |
15,128
-76
| -0.5% | -$3.56K | 0.07% | 177 |
|
|
2024
Q2 | $631K | Sell |
15,204
-1,294
| -8% | -$57.9K | 0.06% | 186 |
|
|
2024
Q1 | $895K | Sell |
16,498
-1,939
| -11% | -$98.8K | 0.09% | 160 |
|
|
2023
Q4 | $946K | Buy |
18,437
+600
| +3% | +$31.5K | 0.11% | 153 |
|
|
2023
Q3 | $1.04M | Buy |
17,837
+6,992
| +64% | +$428K | 0.14% | 127 |
|
|
2023
Q2 | $694K | Hold |
10,845
| – | – | 0.11% | 133 |
|
|
2023
Q1 | $752K | Hold |
10,845
| – | – | 0.13% | 125 |
|
|
2022
Q4 | $780K | Hold |
10,845
| – | – | 0.14% | 126 |
|
|
2022
Q3 | $771K | Hold |
10,845
| – | – | 0.14% | 123 |
|
|
2022
Q2 | $836K | Sell |
10,845
-2,260
| -17% | -$172K | 0.14% | 124 |
|
|
2022
Q1 | $957K | Buy |
13,105
+2,050
| +19% | +$138K | 0.14% | 130 |
|
|
2021
Q4 | $689K | Hold |
11,055
| – | – | 0.09% | 150 |
|
|
2021
Q3 | $655K | Sell |
11,055
-78
| -0.7% | -$5.14K | 0.1% | 152 |
|
|
2021
Q2 | $744K | Sell |
11,133
-4,000
| -26% | -$261K | 0.11% | 146 |
|
|
2021
Q1 | $955K | Sell |
15,133
-90
| -0.6% | -$5.6K | 0.15% | 122 |
|
|
2020
Q4 | $944K | Hold |
15,223
| – | – | 0.16% | 117 |
|
|
2020
Q3 | $918K | Sell |
15,223
-777
| -5% | -$46.8K | 0.17% | 108 |
|
|
2020
Q2 | $941K | Hold |
16,000
| – | – | 0.19% | 104 |
|
|
2020
Q1 | $892K | Buy |
16,000
+830
| +5% | +$50.7K | 0.21% | 99 |
|
|
2019
Q4 | $973K | Buy |
15,170
+520
| +4% | +$29.8K | 0.18% | 110 |
|
|
2019
Q3 | $743K | Hold |
14,650
| – | – | 0.15% | 122 |
|
|
2019
Q2 | $664K | Hold |
14,650
| – | – | 0.14% | 124 |
|
|
2019
Q1 | $699K | Sell |
14,650
-80
| -0.5% | -$3.98K | 0.15% | 122 |
|
|
2018
Q4 | $766K | Sell |
14,730
-1,000
| -6% | -$53.7K | 0.18% | 110 |
|
|
2018
Q3 | $977K | Hold |
15,730
| – | – | 0.21% | 105 |
|
|
2018
Q2 | $870K | Hold |
15,730
| – | – | 0.2% | 108 |
|
|
2018
Q1 | $995K | Buy |
15,730
+3,875
| +33% | +$249K | 0.24% | 102 |
|
|
2017
Q4 | $726K | Sell |
11,855
-200
| -2% | -$12.5K | 0.2% | 104 |
|
|
2017
Q3 | $768K | Hold |
12,055
| – | – | 0.23% | 98 |
|
|
2017
Q2 | $672K | Sell |
12,055
-20
| -0.2% | -$1.09K | 0.22% | 100 |
|
|
2017
Q1 | $657K | Sell |
12,075
-2,050
| -15% | -$112K | 0.22% | 98 |
|
|
2016
Q4 | $825K | Hold |
14,125
| – | – | 0.29% | 89 |
|
|
2016
Q3 | $762K | Sell |
14,125
-500
| -3% | -$32.1K | 0.27% | 92 |
|
|
2016
Q2 | $1.08M | Sell |
14,625
-630
| -4% | -$44.5K | 0.38% | 79 |
|
|
2016
Q1 | $974K | Sell |
15,255
-2,200
| -13% | -$139K | 0.36% | 82 |
|
|
2015
Q4 | $1.2M | Buy |
17,455
+850
| +5% | +$56.2K | 0.38% | 78 |
|
|
2015
Q3 | $983K | Hold |
16,605
| – | – | 0.33% | 83 |
|
|
2015
Q2 | $1.1M | Buy |
16,605
+735
| +5% | +$48.4K | 0.34% | 81 |
|
|
2015
Q1 | $1.02M | Hold |
15,870
| – | – | 0.32% | 84 |
|
|
2014
Q4 | $937K | Sell |
15,870
-900
| -5% | -$50.8K | 0.29% | 86 |
|
|
2014
Q3 | $858K | Sell |
16,770
-72
| -0.4% | -$3.6K | 0.28% | 86 |
|
|
2014
Q2 | $817K | Sell |
16,842
-1,930
| -10% | -$95.1K | 0.27% | 87 |
|
|
2014
Q1 | $975K | Sell |
18,772
-150
| -0.8% | -$7.98K | 0.35% | 78 |
|
|
2013
Q4 | $1.01M | Buy |
18,922
+900
| +5% | +$45.8K | 0.36% | 78 |
|
|
2013
Q3 | $834K | Buy |
18,022
+1,300
| +8% | +$57.1K | 0.33% | 77 |
|
|
2013
Q2 | $747K | Buy |
+16,722
| New | +$726K | 0.31% | 79 |
|
Other funds holding BMY
AIM
FWIA
DLA
Penobscot Investment Management's BMY Position: Q2 2026 in Review
Penobscot Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, selling an estimated $20.1K and leaving 13,428 shares worth $774K. The position accounts for 0.05% of the portfolio, ranked #187.
Penobscot Investment Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.2M in Q4 2015. 949 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Penobscot Investment Management held 13,428 shares of Bristol-Myers Squibb worth $774K as of Q2 2026.
- Penobscot Investment Management sold 350 Bristol-Myers Squibb shares in Q2 2026, an estimated $20.1K.
- Bristol-Myers Squibb made up 0.05% of Penobscot Investment Management's portfolio in Q2 2026, its #187 holding.
- Penobscot Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Penobscot Investment Management's Bristol-Myers Squibb position peaked at $1.2M in Q4 2015.
- 949 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.